TrialEuropean journal of heart failure2021

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.

Pooja Dewan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.